Humoral immunity to herpes simplex virus type 2 in cervical cancer
Posevaia, T.A.; Barinskiĭ, I.F.; Grigor'ev, V.V.; Shuvaeva, N.I.
Voprosy Virusologii 27(3): 328-330
1982
ISSN/ISBN: 0507-4088 PMID: 6289530 Document Number: 185520
The analysis of the results of serological studies revealed differences between the number of positively reacting sera from patients with cervical carcinoma and from normal women. The activity of complement-fixing and virus-neutralizing antibodies in the patients' sera and the frequency of their detection were higher than in the sera from normal subjects. These results in combination with other methods of laboratory examinations may be used for early detection of cervical carcinoma as well as for determination of high risk groups with regard to oncological diseases.
Document emailed within 1 workday
Related Documents
Biesiadecka, A. 2000: Immunogenic activity of temperature sensitive mutation of herpes simplex virus type-1 in mono- and polyvalent conditions with different attenuated strains of virus. I. Analysis of humoral immunity induced by mutant temperature sensitive herpes simplex virus type-1 in monovalent systems Medycyna Doswiadczalna i Mikrobiologia 52(1): 81-88Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Colette Smit, C.P.,A.M.,J.T.,J.S.,B.B.,R.C.andN.H.T.M.D. 2007: Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and Hiv over time (19842003) European Journal of Epidemiology 22(12): 937-944
Anzai, T.; Dreesman, G.R.; Courtney, R.J.; Adam, E.; Rawls, W.E.; Benyesh-Melnick, M. 1975: Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups Journal of the National Cancer Institute 54(5): 1051-1059
Suligoi, B.; Torri, A.; Grilli, G.; Tanzi, E.; Palú, G. 2004: Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy Sexually Transmitted Diseases 31(10): 608-610
Gilman, S.C.; Docherty, J.J.; Clarke, A.; Rawls, W.E. 1980: Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls Cancer Research 40(12): 4640-4647
Parr, M.B.; Kepple, L.; McDermott, M.R.; Drew, M.D.; Bozzola, J.J.; Parr, E.L. 1994: A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2 Laboratory Investigation; a Journal of Technical Methods and Pathology 70(3): 369-380
Goodheart, C.R. 1974: Biochemical approaches to detection of herpes simplex virus type 2 in cervical carcinoma Cancer Research 34(5): 1136-1139
Te Velde, E.R.; The, T.H. 1978: Herpes simplex virus type 2 and cervix cancer Nederlands Tijdschrift Voor Geneeskunde 122(33): 1226-1230
Vestergaard, B.F. 1982: A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes Developments in Biological Standardization 52: 95-98
Puthavathana, P.; Kanyok, R.; Horthongkham, N.; Roongpisuthipong, A. 1998: Prevalence of herpes simplex virus infection in patients suspected of genital herpes; and virus typing by type specific fluorescent monoclonal antibodies Journal of the Medical Association of Thailand 81(4): 260-264
Long, Y.; Mi, Y.; Li, Y. 2008: Progess on research of herpes simplex virus type 1 mutants for cancer therapy Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 25(6): 1446-1449
Slomka, M.J. 1996: Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus Communicable Disease Report. Cdr Review 6(3): R41-R45
Scoular, A.; Leask, B.G.; Carrington, D. 1990: Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88 Genitourinary Medicine 66(3): 226
Abe, Y.; Kobayashi, S. 1982: The DNA restriction enzyme analyses of herpes simplex virus type 1 isolates from cases of ocular herpes Nippon Ganka Gakkai Zasshi 86(8): 867-869
Kruglova, A.I.; Nikolaeva, N.P.; Niukhalova, I.V.; Barinskiĭ, I.F.; Alimbarova, L.M.; Demkin, V.V. 2004: Polymorphism of herpes simplex virus type 1 and 2 DNA from laboratory strains and clinical material from patient with genital herpes Voprosy Virusologii 49(1): 23-27
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Nash, A.A.; Phelan, J.; Wildy, P. 1981: Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response Journal of Immunology 126(4): 1260-1262
Prober, C.G.; Sullender, W.M.; Yasukawa, L.L.; Au, D.S.; Yeager, A.S.; Arvin, A.M. 1987: Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections New England Journal of Medicine 316(5): 240-244